Acute pancreatitis occurring after pamidronate infusions in two patients with spondyloarthritis
- PMID: 23844305
- PMCID: PMC3697230
- DOI: 10.1155/2013/912692
Acute pancreatitis occurring after pamidronate infusions in two patients with spondyloarthritis
Abstract
We report two cases of acute pancreatitis following the administration of pamidronate given as an anti-inflammatory agent for spondyloarthritis with a recurrence in one patient when the drug was reintroduced. The upper gastrointestinal toxicity of aminobisphosphonates is well known and this drug class could be added to the list of medications that are associated with the development of pancreatitis.
References
-
- Balani AR, Grendell JH. Drug-induced pancreatitis: incidence, management and prevention. Drug Safety. 2008;31(10):823–837. - PubMed
-
- Nitsche CJ, Jamieson N, Lerch MM, Mayerle JV. Drug induced pancreatitis. Best Practice and Research: Clinical Gastroenterology. 2010;24(2):143–155. - PubMed
-
- Toussirot É, Wendling D. Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis. Current Opinion in Rheumatology. 2007;19(4):340–345. - PubMed
-
- Khosla S, Bilezikian JP, Dempster DW, et al. Benefits and risks of bisphosphonate therapy for osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 2012:2272–2282. - PubMed
-
- Farcas A, Bojita M. Adverse drug reactions in clinical practice: a causality assessment of a case of drug-induced pancreatitis. Journal of Gastrointestinal and Liver Diseases. 2009;18(3):353–358. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
